2nd Outsourcing in Clinical Trials China 2026 中国临床试验外包大会

Event Date(s) :
Tuesday, Sept 08, 2026
Wednesday, Sept 09, 2026
Tags :
Central Laboratory
Clinical Trials
Outsourcing
BioPharma
CRO
China

Why attend? 为何参会?

Access Local Expertise: Gain insights into the unique challenges and opportunities within China’s clinical trials landscape, directly from local and international experts.

获取本土洞见
直击中国临床试验生态的独特挑战与机遇,聆听中外专家的第一手经验分享。

Regulatory Updates: Stay ahead with the latest regulatory developments and compliance strategies essential for navigating China’s evolving healthcare environment.

掌握法规动态
获取中国快速演变的医疗监管政策最新进展,学习合规策略以规避风险。

Industry Networking: Build meaningful connections with leading CROs, biopharmaceutical companies, and other stakeholders driving clinical trial success in China.

拓展行业人脉
与推动中国临床试验成功的CRO龙头企业、生物制药公司及行业决策者建立深度合作。

Strategic Collaboration: Explore strategies to optimize outsourcing partnerships and discover tailored solutions for managing clinical trial operations in a complex, dynamic market.

优化合作战略
探索复杂动态市场中的外包合作模式,定制化临床运营解决方案。

Emerging Trends: Delve into cutting-edge technologies and methodologies shaping the future of clinical trials in China, from digital tools to innovative supply chain solutions.

前瞻未来趋势
聚焦数字化工具与创新供应链等前沿技术,洞察中国临床试验的未来形态。
 

Taking place September 8-9, 2026, at the Renaissance Suzhou Hotel,  OCT China offers a collaborative forum for meaningful discussion, knowledge exchange, and partnership-building within the clinical research ecosystem.

Kevin JD Smith, Senior Vice President // Operations & Scientific Affairs, will be presenting the following topic:

Bridging Global Standards and Local Scientific Excellence: Delivering Reliable Clinical Trial Testing in China 链接全球标准与本土科学:在中国交付可靠的临床试验检测

Date: 09 September 2026

Time: 09.30

Connect with Eurofins Central Laboratory at Booth 32 to learn how our global central laboratory solutions support clinical trials across all phases of development.

As part of Eurofins Central Laboratory’s global network of five wholly owned, CAP-accredited laboratories across the United States, Europe, Singapore, and China, our Shanghai facility offers sponsors and CROs the advantages of local execution within a globally harmonized central laboratory model. This combination of in-country infrastructure, scientific expertise, and internationally aligned quality standards enables reliable clinical trial testing in China while supporting consistency, comparability, and confidence across global study programs.

Schedule time with our experts to discuss upcoming studies, operational challenges, and strategies to optimize laboratory execution within your overall clinical trial strategy.

Request a meeting